Simple Summary Chronic alcoholic pancreatitis displays a cumulative risk of pancreatic
cancer estimated at 4% after 15 to 20 years, this risk being higher for hereditary pancreatitis …

Gastric cancer (GC) represents a significant burden of cancer-related mortality worldwide,
underscoring an urgent need for the development of early detection strategies and precise …

Introduction Most patients with pancreatic cancer present with advanced stage, incurable
disease. However, patients with high-grade precancerous lesions and many patients with …

Pancreatic cancer, notorious for its late diagnosis and aggressive progression, poses a
substantial challenge owing to scarce treatment alternatives. This review endeavors to …

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with five-year
survival rates around 10%. The only curative option remains complete surgical resection, but …

Liquid biopsy, a novel detection method, has recently become an active research area in
clinical cancer owing to its unique advantages. Studies on circulating free DNA, circulating …

Pancreatic cancer (PC) is an increasing cause of cancer-related death, with a dismal
prognosis caused by its aggressive biology, the lack of clinical symptoms in the early phases …

Introduction Chronic pancreatitis is a heterogeneous and complex syndrome that, in most
cases, causes pain as a cardinal symptom and affects both the morphology and function of …

Background Chronic pancreatitis (CP) may cause tumor-like lesions, creating a challenge in
distinguishing between CP and pancreatic ductal adenocarcinoma (PDAC) in a patient …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor survival.
Novel biomarkers are urgently needed to improve the outcome through early detection …